Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Leukemia in Relapse (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT05038644
What this trial is testing

XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia

Who this might be right for
Acute Myeloid LeukemiaT Cell Acute Lymphoblastic LeukemiaT Cell Lymphoblastic Lymphoma
Ehab L Atallah 22
Not applicableStudy completedNCT00996047
What this trial is testing

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
SWOG Cancer Research Network 3,341
Testing effectiveness (Phase 2)Study completedNCT04055844
What this trial is testing

Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS

Who this might be right for
Acute Myeloid LeukemiaMyeloid and Monocytic LeukemiaMyelodysplastic Syndromes
Masonic Cancer Center, University of Minnesota 14
Testing effectiveness (Phase 2)Study completedNCT06865352
What this trial is testing

Safety and Preliminary Efficacy of Donor-derived Anti-leukemia Cytotoxic T Lymphocytes for the Prevention of Leukemia Relapse in Children Given Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia ALLAcute Myeloid Leukemia (AML)
Fondazione IRCCS Policlinico San Matteo di Pavia 15
Early research (Phase 1)Not Yet RecruitingNCT07841002
What this trial is testing

CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML)
Liping Dou 12
Testing effectiveness (Phase 2)Study completedNCT01295307
What this trial is testing

Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 86
Testing effectiveness (Phase 2)Study completedNCT03701295
What this trial is testing

Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement

Who this might be right for
Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLLLeukemia CutisRecurrent Acute Myeloid Leukemia+1 more
National Cancer Institute (NCI) 1
Not applicableStudy completedNCT06463639
What this trial is testing

FLT3 Clonal Evolution in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
National Taiwan University Hospital 1,213
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)UnknownNCT05731219
What this trial is testing

UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 18
Testing effectiveness (Phase 2)Ended earlyNCT04240002
What this trial is testing

Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
Astellas Pharma Global Development, Inc. 9
Early research (Phase 1)Study completedNCT01830777
What this trial is testing

Brentuximab Vedotin + Re-induction Chemotherapy for AML

Who this might be right for
Acute Myelogenous Leukemia
Massachusetts General Hospital 22
Testing effectiveness (Phase 2)UnknownNCT05951855
What this trial is testing

Study of Selinexor Combined With Chidamide in Relapsed/Refractory Acute Leukemia (AML) Patients

Who this might be right for
Acute Myeloid Leukemia (Relapsed/Refractory)
The First Affiliated Hospital of Soochow University 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT02790515
What this trial is testing

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more
St. Jude Children's Research Hospital 170
Not applicableStudy completedNCT05456048
What this trial is testing

Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML

Who this might be right for
Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaGene Abnormality+1 more
Nanfang Hospital, Southern Medical University 231
Testing effectiveness (Phase 2)Ended earlyNCT02152956
What this trial is testing

Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)

Who this might be right for
AML
MacroGenics 244
Large-scale testing (Phase 3)Study completedNCT00002456
What this trial is testing

Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
Fred Hutchinson Cancer Center
Early research (Phase 1)Looking for participantsNCT07668557
What this trial is testing

Anti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
iCell Gene Therapeutics 18
Early research (Phase 1)Study completedNCT05548088
What this trial is testing

LILRB4 STAR-T Cells in the Treatment of R/R AML/CMML

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia and Chronic Granulocytic-Mononocytic Leukemia
Peking University People's Hospital 11
Testing effectiveness (Phase 2)Ended earlyNCT04639024
What this trial is testing

ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Myeloproliferative Neoplasm (MDS/MPN)
Gwynn Long, M.D. 3
Next Page